Hypertension in Pregnancy and Postpartum: Current Standards and Opportunities to Improve Care

M Malamo Countouris (UPMC, PIttsburgh, Pennsylvania, United States) Z Zainab Mahmoud (Washington University in St. Louis, St. Louis, MO (M.D.H., A.V., Z.M.).) J Jordana B. Cohen D Daniela Crousillat (Department of Medicineand Obstetrics and Gynecology, Division of Cardiovascular Sciences, University of South Florida Morsani College of Medicine, Tampa General Hospital Heart and Vascular Institute (D.C.).) A Afshan B. Hameed C Colleen M. Harrington (Department of Medicine, Division of Cardiology, Women’s Heart Health Program, Massachusetts General Hospital, Boston (C.M.H., M.C.H., A.S.).) A Alisse Hauspurg M Michael C. Honigberg J Jennifer Lewey (Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States) K Kathryn Lindley (Vanderbilt University, Nashville, Tennessee, United States) M Megan M. McLaughlin N Neha Sachdev (American Medical Association, Chicago, IL (N.S.).) A Amy Sarma (Department of Medicine, Division of Cardiology, Women’s Heart Health Program, Massachusetts General Hospital, Boston (C.M.H., M.C.H., A.S.).) K Kayle Shapero (Brown University Health Cardiovascular Institute (K.S.), Alpert Medical School of Brown University, Providence, RI.) R Rachel Sinkey (UAB, Birmingham, Alabama, United States) A Alan Tita (University of Alabama at Birmingham, Birmingham, Alabama, United States) K Kristen E. Wong (Department of Medicine, Division of Cardiology, Washington University in St Louis, MO (Z.M., K.E.W.).) E Eugene Yang L Leslie Cho N Natalie A. Bello

Abstract

Hypertension in pregnancy contributes substantially to maternal morbidity and mortality, persistent hypertension, and rehospitalization. Hypertensive disorders of pregnancy are also associated with a heightened risk of cardiovascular disease, and timely recognition and modification of associated risk factors is crucial in optimizing long-term maternal health. During pregnancy, there are expected physiologic alterations in blood pressure (BP); however, pathophysiologic alterations may also occur, leading to preeclampsia and gestational hypertension. The diagnosis and effective management of hypertension during pregnancy is essential to mitigate maternal risks, such as acute kidney injury, stroke, and heart failure, while balancing potential fetal risks, such as growth restriction and preterm birth due to altered uteroplacental perfusion. In the postpartum period, innovative and multidisciplinary care solutions that include postpartum maternal health clinics can help optimize short- and long-term care through enhanced BP management, screening of cardiovascular risk factors, and discussion of lifestyle modifications for cardiovascular disease prevention. As an adjunct to or distinct from postpartum clinics, home BP monitoring programs have been shown to improve BP ascertainment across diverse populations and to lower BP in the months after delivery. Because of concerns about pregnant patients being a vulnerable population for research, there is little evidence from trials examining the diagnosis and treatment of hypertension in pregnant and postpartum individuals. As a result, national and international guidelines differ in their recommendations, and more studies are needed to bolster future guidelines and establish best practices to achieve optimal cardiovascular health during and after pregnancy. Future research should focus on refining treatment thresholds and optimal BP range peripartum and postpartum and evaluating interventions to improve postpartum and long-term maternal cardiovascular outcomes that would advance evidence-based care and improve outcomes worldwide for people with hypertensive disorders of pregnancy.

Article Details

Journal Circulation
Volume / Issue Vol. 151, Issue 7
Published February 18, 2025
Pages 490-507
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (20)

M

Malamo Countouris

UPMC, PIttsburgh, Pennsylvania, United States

Z

Zainab Mahmoud

Washington University in St. Louis, St. Louis, MO (M.D.H., A.V., Z.M.).

J

Jordana B. Cohen

D

Daniela Crousillat

Department of Medicineand Obstetrics and Gynecology, Division of Cardiovascular Sciences, University of South Florida Morsani College of Medicine, Tampa General Hospital Heart and Vascular Institute (D.C.).

A

Afshan B. Hameed

C

Colleen M. Harrington

Department of Medicine, Division of Cardiology, Women’s Heart Health Program, Massachusetts General Hospital, Boston (C.M.H., M.C.H., A.S.).

A

Alisse Hauspurg

M

Michael C. Honigberg

J

Jennifer Lewey

Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

K

Kathryn Lindley

Vanderbilt University, Nashville, Tennessee, United States

M

Megan M. McLaughlin

N

Neha Sachdev

American Medical Association, Chicago, IL (N.S.).

A

Amy Sarma

Department of Medicine, Division of Cardiology, Women’s Heart Health Program, Massachusetts General Hospital, Boston (C.M.H., M.C.H., A.S.).

K

Kayle Shapero

Brown University Health Cardiovascular Institute (K.S.), Alpert Medical School of Brown University, Providence, RI.

R

Rachel Sinkey

UAB, Birmingham, Alabama, United States

A

Alan Tita

University of Alabama at Birmingham, Birmingham, Alabama, United States

K

Kristen E. Wong

Department of Medicine, Division of Cardiology, Washington University in St Louis, MO (Z.M., K.E.W.).

E

Eugene Yang

L

Leslie Cho

N

Natalie A. Bello